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Infertility is a significant public health problem and its diagnosis and treatment are stressful,
invasive and costly. Impaired fecundity is a growing health concern worldwide. Fertility
predominantly depends on the maintenance of the quantity and quality of the ovarian reserve,
which is determined by the extrinsic and intrinsic factors. The reserve declines with consumption
of the follicle as age increases and by the imbalance in the redox activity.
Cellular redox activity is a normal mechanism of the male and female reproductive system
but its inequilibrium affects the fertility by hindering attainment and maintenance of oocyte
developmental potential during in vivo processes including ovarian aging. Oxidative stress (OS) has
been associated with decreased female fecundity in animal and in vitro models, but no studies to
date have directly assessed the relationship in women. Exposures associated with OS and pregnancy
outcomes have so far been studied in relation to Poly Cystic Ovarian Syndrome (PCOS) only.
Sirtuin (silent information regulator, SIRT), family of NAD dependent enzymes is evolving as main
regulator of OS. They are known to repair cells damaged due to OS by stimulating the expression
of antioxidants and thus preventing dysfunction of the ovarian cells. SIRT1 signaling initiates a
positive ovarian cells response by catalyzing an enzymatic reaction between nicotinamide and
the acetyl group of the substrate, transferring it to cleave NAD, generating a unique metabolite,
O-acetyl-ADP ribose (Pillarisetti, 2008). Alterations in cellular NAD levels, or the NAD-NADH
ratio, are the primary mechanisms controlling SIRT1 expression and activity(Guarente and Picard,
2005).
As far as the impact of Os on oocyte is concerned; under influence of various external and
internal factors, when the oocytes start aging and generating advanced glycation end products
(AGEs) in the ovarian microenvironment, there is a trigger for the generation of intracellular
reactive oxygen species ROS by down regulation of NAD(P)H oxidase, mitogen-activated protein
kinases (MAPKs), and the transcription factor, nuclear factor kappa B (NF-.B) (Lander et al., 1997;
Xu and Kyriakis, 2003) leading to proinflammatory milieu and an increase in OS (Mohamed et al.,
1999; Schmidt et al., 2001). Lipid peroxidation during OS is capable of commencing cyclic ROS
dissemination via direct damage to mtDNA (mitochondrial DNA) and proteins. With increase
concentrations of ROS within the oocytes, mitochondria lose their potential to culminate the state
of auto-oxidation by decreased production of ATP from the electron transport chain (ETC), thus
aggravating damage to mitochondrial functional components.
Mitochondria being a key player in calcium regulation in the oocytes for generation of the main
bulk of ATP for the processes like apoptosis and completion of meiosis including spindle assembly,
under the influence of ROS within the ovaries is considered as the main cause for chromosomal
segregation disorders, maturation, and fertilization failures, or oocyte/embryo fragmentation.
Presence of systemic and follicular oxidative stress markers in patients of endometriosis have
also been identified (Takeuchi et al., 2005). Maintenance of the oxidative environment within the
oocytes is an essential process, which needs to be guarded and carried out by the regulators.
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FIGURE 1 | A hypothetical view of the possible mechanisms by which Metformin helps in maintaining the microenvironment of the granulosa cells. With advancing
age of the oocytes, development of oxidative stress takes place which leads to imbalance between the oxidants and the antioxidants thus elevating reactive oxygen
species, lipid peroxidation and simultaneously decreasing the expression of SIRT1 via decreased NAD/NADPH ratio (STEP1). These changes lead to mitochondrial
dysfunction by direct injury to the mitochondrial DNA (STEP2) depleting ATP synthesis by the electron transport chain (STEP3). Oocyte maturation failure,
chromosomal segregation disorders & oocyte/embryo fragmentation occurs (STEP4) as a result causing infertility. Metformin moderates the expression of SIRT1
directly and by regulating the NAD/NADPH ratio which also in turn increases the concentration of SIRT1. It is also believed to buffer the ROS by increasing the
concentration of Glutathione. NAD(P)H, Nicotinamide adenine dinucleotide phosphate; MAPKs, mitogen-activated protein kinase; ROS, reactive oxygen species;
mtDNA, mitochondrial DNA; SIRT, Sirtuin; ATP, Adenosine-5-triphosphate.

the intact cells. Among the cell signaling pathways capable of
mitochondrial regulation, metformin contribute to increase in
the glutathione content, thus providing aid in encountering the
ROS (Figure 1). Metformin induces increase in NAD/NADH
ratio by inducing increased expression of NAMPT mRNA and
protein expression, resulting in enhanced SIRT1 expression and
activity in a dose-dependent fashion (Caton et al., 2010).
Metformin has been a choice in treating PCOS as a single
as well as in adjuvant therapy. Despite being successfully
administered postulating its classical effect on insulin sensitivity
on the cell surface yet its exact action is ill-defined. It
induces rise in NAD/NADH ratio by triggering increased
expression of NAMPT mRNA, resulting in enhanced
SIRT1 expression and activity in a dose-dependent fashion.
However pathway proposed in another recent study is it’s
action on SIRT1 expression by increasing a rate-limiting
cytokine in NAD biosynthesis, visfatin(Reverchon et al.,
2013).
A previous meta-analysis published on 2006 could not
verify the role of Metformin in gonadotropin ovulation
induction (Costello et al., 2006). However some studies
have validated the benefits of Metformin treatment in

Significant inhibition of SIRT1 mRNA has also been observed
with increase in ROS, compromising the nuclear maturation and
the mitotic spindles of the maturing oocytes.
An independent study conducted in Pakistan suggests that
functions of SIRT1 are affected by various post-transcriptional
activities; increased by phosphorylation, while glycosylation
decreased it (Hanover et al., 2010). It utilizes unique pathways;
its glycosylation occurs through the hexoseamine-signaling
pathway (Hanover et al., 2010), furthermore, SIRT1-dependent
gluconeogenesis is also intermediated by changes in the levels
of NAD and pyruvate instead of employing gluconeogenic
regulatory hormones (Rodgers et al., 2005). The crosstalk
between various post-translational modifications regulates the
proteins functionally that control the transcriptional activity of
various genes(Hoessli et al., 2013). Addition of O-GlcNAc during
the process of aging and development of diabetes weakens the
activity of SIRT.
Metformin; (generic name; Dimethylbiguanide), widely used
hypoglycemic drug utilizing its capability of inhibiting hepatic
gluconeogenesis. It is recently known to inhibit cellular
respiration carried out by the mitochondria in the hepatic
cells, however its effect is dose-dependent and less potent on
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biosynthesis and increasing the expression of SIRT1, thus
improving the reproductive microenvironment in infertile
females. Oxidative environment of the granulosa cells in presence
of SIRT1 polymorphism might be improved by the use of
Metformin.

PCOS patients by reducing risk of miscarriage and of
implantation failure in IVF cycles (Palomba et al., 2013).
This suggests that Metformin offer much more than
what is known. During the periods of stress, metformin
regulates the cellular metabolic machinery and ensure cell
survival by regulating the co-ordination among several
different age related transcription factor pathways previously
mentioned.
Insights into the role of Metformin in decreasing OS in the
gynecologic environment might be helpful in understanding
the potential of Metformin as an inexpensive and non-invasive
therapy for increasing fertility and decreasing the cost of
treatment especially in couples with options like in vitro
fertilization (IVF) & intracytoplasmic sperm injection (ICSI)
that are expensive and still have a limited success rate of
25–30%. Studies do support conservation of fertility treatments
that instigate a SIRT1 mediated decrease in ROS due to aging
and OS.
On a larger scale, studies do support conservation of
fertility treatments that instigate SIRT1 mediated decrease in
ROS under the circumstances of aging and OS. However,
no human study refers to the role of MetF during OS
in presence of SIRT1 genetic polymorphism of infertile
females. Further comprehensive studies are needed to verify
this function of MetF in infertility. This pioneering study,
therefore, aims to identify the role of MetF on oxidative
stress with existing SIRT1 Polymorphism in infertile
cases where SIRT1 polymorphism is associated with aging
and OS.

RECOMMENDATIONS
Genetic studies along with cell lines studies are stipulated
in order to identify the authentic role of Metformin in
decreasing OS in the gynecologic microenvironment. This
might surface an inexpensive and non-invasive therapy for
increasing fertility and decreasing the cost of treatment especially
in couple that are left-with no options other than in vitro
fertilization (IVF) & intracytoplasmic sperm injection and still
have a negative outcome. Metformin could be incorporated
as a part of clinical trials in polymorphic infertile patients,
if proven could lead to successful outcomes by cost-effective
treatments.
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HYPOTHESIS
We hypothesized that Metformin buffers the increased OS
in presence of SIRT1 polymorphism by regulating the NAD
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